Tamoxifen: Will Less Equal More in Women with Precancerous Breast Disease?

被引：0
|
作者：
Fabian, Carol J. [1 ]
机构：
[1] Univ Kansas, Div Clin Oncol, Dept Internal Med, Med Ctr, Kansas City, KS USA
来源：
CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 13期
关键词：
CANCER; EXPRESSION;
D O I：
10.1158/1078-0432.CCR-21-0729
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Similar risk reduction but fewer side effects would predict more uptake and compliance with low (5 mg) versus full (20 mg) dose tamoxifen. Benefit with low dose is demonstrated for perimenopausal/postmenopausal women with intraepithelial neoplasia and high lesion Ki-67. Longer follow-up needed to determine benefit with low lesion Ki-67.
引用
收藏
页码：3510 / 3511
页数：2
相关论文
共 50 条
  • [31] Effects of Tamoxifen on the endometrium of women with breast cancer
    丁颖
    孙爱军
    生殖医学杂志, 2009, 18(S2) (S2) : 90 - 94
  • [32] More than a disease: Older women and breast cancer treatment
    Evans, Carol
    Benjamin, Christine
    Ryan, Joanne C.
    Johnson, Katrina M.
    Mayes, Gwen
    CANCER RESEARCH, 2022, 82 (04)
  • [33] Tamoxifen and fenretinide in women with metastatic breast cancer
    J. Zujewski
    L. Pai
    L. Wakefield
    R. Giusti
    F.A. Dorr
    C. Flanders
    R. Caruso
    M. Kaiser
    L. Goodman
    M. Merino
    M. Gossard
    M.A. Noone
    A. Denicoff
    D. Venzon
    K.H. Cowan
    J.A. O'Shaughnessy
    Breast Cancer Research and Treatment, 1999, 57 : 277 - 283
  • [34] Histeroscopy in women treated with tamoxifen for breast cancer
    Saia, C.
    Leotta, E.
    Cannone, F.
    Militello, M. P.
    Garozzo, V.
    PROCEEDINGS OF THE 1ST AAGL INTERNATIONAL CONGRESS ON MINIMALLY INVASIVE GYNECOLOGY & 4TH SEGI ANNUAL MEETING, 2007, : 205 - 207
  • [35] Tamoxifen for breast cancer among hysterectomised women
    Veronesi, U
    Maisonneuve, P
    Sacchini, V
    Rotmensz, N
    Boyle, P
    LANCET, 2002, 359 (9312): : 1122 - 1124
  • [36] Tamoxifen for treatment of premenopausal women with breast cancer
    Lam, RY
    Chlebowski, RT
    CANCER INVESTIGATION, 2000, 18 (07) : 681 - 684
  • [37] Tamoxifen and breast density in women at increased risk of breast cancer
    Cuzick, J
    Warwick, J
    Pinney, E
    Warren, RML
    Duffy, SW
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08): : 621 - 628
  • [38] Tamoxifen and the breast cancer prevention trial: Women helping women
    Healy, BP
    JOURNAL OF WOMENS HEALTH, 1998, 7 (03) : 279 - 280
  • [39] Is fulvestrant more effective than tamoxifen for treating ER-positive breast cancer in postmenopausal women?
    Raina, Vinod
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (01): : 20 - 21
  • [40] Cardiovascular effects of tamoxifen in women with and without heart disease: Breast cancer prevention trial
    Reis, SE
    Costantino, JP
    Wickerham, DL
    Tan-Chiu, E
    Wang, JP
    Kavanah, M
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (01) : 16 - 21
12345